The data we've been collecting is evolving quickly, and these women are living with this information in real time," [Domchek] said in an e-mail. "Since 1994 enormous progress had occurred... genes have been cloned, clinically available tests for gene mutations have been developed, and the implications of having BRCA1/2 mutations are better understood. Women as young as 25 are using this data to make informed choices."
CNN reports on studies indicating that more women with early-stage breast cancer are opting for double mastectomies, quoting Susan Domchek, MD, Executive Director of the Basser Research Center for BRCA.
Click here for the full CNN report
0 comments:
Post a Comment